Lv57
986 积分 2024-05-16 加入
The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives
19天前
已完结
Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure
20天前
已完结
Exploring DESTINY: the Past, Present, and Future of Trastuzumab Deruxtecan
25天前
已完结
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
1个月前
已完结
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
1个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
1个月前
已完结
The race to reset autoimmune diseases
1个月前
已完结
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials
1个月前
已关闭
B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus
1个月前
已完结
A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases
2个月前
已完结
皖公网安备34019202002308
